Columbia Care To Raise $25.2 Million In Bought Deal Financing

Columbia Care (CSE: CCHW) is the latest firm to announce a financing. The company this morning announced that it will be conducting a bought deal financing to raise gross proceeds of $25.2 million in a financing lad by Canaccord Genuity.

The financing will see a total of 2.8 million shares of the issuer sold at a price of $9.00 per share to raise gross proceeds of $25.2 million. No warrant is to be issued in connection with the offering, with the offering expected to be sold primarily to one large institutional investor, however a name was not provided.

An over-allotment option has also been granted by the company, valid until the closing of the offering.

Emerita Resources Corp. — sponsored Sponsored · Emerita Resources Corp.

Proceeds from the financing are to be used for working capital and general corporate purposes.

The financing is expected to close February 25, 2021.

Columbia Care last traded at $9.78 on the CSE.


Information for this briefing was found via Sedar and Columbia Care Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Trending

Related News

Columbia Care Posts Q4 Revenues Of $139.3 Million, Net Loss

Columbia Care (NEO: CCHW) this morning reported its fourth quarter and full year financial results,...

Thursday, March 24, 2022, 09:21:13 AM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

P Diddy To Spend $185 Million Acquiring Cannabis Assets From Cresco Labs, Columbia Care

Cresco Labs (CSE: CL) appears to be monetizing the appointment of director Tarik Brooks, which...

Friday, November 4, 2022, 08:44:11 AM

Canaccord Lowers Targets On Numerous Top Level Cannabis Equities

On February 4th, Canaccord Genuity came out with their cannabis fourth quarter 2021 preview. On...

Monday, February 7, 2022, 01:30:00 PM

Haywood Cuts Cresco Labs Price Target To $15.50 On Poor Earnings

At the tail end of March, Cresco Labs (CSE: CL) announced its fourth-quarter financial results,...

Sunday, April 3, 2022, 03:09:00 PM